1. Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol. 2010;25:19-26. DOI: https://doi.org/10.1007/s00467-009-1230-x.
2. Chen JY, Mao JH. Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management. World J Pediatr. 2015;11:29-34. DOI: https://doi.org/10.1007/s12519-014-0534-5.
3. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69:798-806. DOI: https://doi.org/10.1136/ard.2009.116657.
4. Davin JC, Coppo R. Henoch-Schönlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563-73. DOI: https://doi.org/10.1038/nrneph.2014.126.
5. Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, et al. Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci. 2013;59:15-26. DOI: https://doi.org/10.5387/fms.59.15.
6. Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet. 2007;369:976-8. DOI: https://doi.org/10.1016/S0140-6736(07)60474-7.
7. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197-202. DOI: https://doi.org/10.1016/S0140-6736(02)11279-7.
8. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein Purpura in an unselected childhood population. Eur J Pediatr. 1988;147:113-5. DOI: https://doi.org/10.1007/BF00442205.
9. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of kidney involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr. 2002;161:196-201. DOI: https://doi.org/10.1007/s00431-002-0922-z.
10. Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura. Scand J Rheumatol. 2006;35:56-60. DOI: https://doi.org/10.1080/03009740510026841.
11. Kaku Y, Nohara K, Honda S. Kidney involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int. 1998;53:1755-9. DOI: https://doi.org/10.1046/j.1523-1755.1998.00915.x.
12. Trnka P. Henoch-Schönlein purpura in children. J Paediatr Child Health. 2013;49:995-1003. DOI: https://doi.org/10.1111/jpc.12403.
13. Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C. Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics. 2007;120:1079-87. DOI: https://doi.org/10.1542/peds.2007-0667.
14. Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241-7. DOI: https://doi.org/10.1016/j.jpeds.2006.03.024.
15. de Almeida JLJ, Campos LMA, Paim LB, Leone C, Koch VHK, Silva CAA. Kidney involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J). 2007;83:259-66. DOI: https://doi.org/10.2223/jped.1638.
16. Narchi H. Risk of long-term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90:916-20. DOI: https://doi.org/10.1136/adc.2005.074641.
17. Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, et al. Renal manifestations of Henoch-Schönlein purpura in a 6-month prospective study of 223 children. Arch Dis Child. 2010;95:877-82. DOI: https://doi.org/10.1136/adc.2009.182394.
18. 18. Levin A, Stevens PE, Bilous RW, Coresh J, de Fransisco ALM, de Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:5-14. DOI: https://doi.org/10.1038/kisup.2012.75.
19. Ghrahani R, Ledika MA, Sapartini G, Setiabudiawan B. Age of onset as a risk factor of kidney involvement in Henoch-Schönlein purpura. Asia Pac Allergy. 2014;4:42-7. doi:10.5415/apallergy.2014.4.1.42
20. Sugianti I, Akib AA, Soedjatmiko S. Karakteristik purpura Henoch-Schönlein pada anak di Rumah Sakit Cipto Mangunkusumo. Sari Pediatr. 2016;16:128. DOI: https://doi.org/10.14238/sp16.2.2014.128-35.
21. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626-38. DOI: https://doi.org/10.1038/nri.2016.90.
22. Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schönlein purpura: a literature review. Acta Derm Venereol. 2017;97:1160-6. DOI: https://doi.org/10.2340/00015555-2733.
23. Chan H, Tang YL, Lv XH, Zhang GF, Wang M, Yang HP, et al. Risk factors associated with renal involvement in childhood Henoch-Schönlein purpura: a meta-analysis. PLoS One. 2016;11(11). DOI: https://doi.org/10.1371/journal.pone.0167346.
24. Fretzayas A, Sionti I, Moustaki M, Papadimitriou A, Nicolaidou P. Henoch-Schönlein purpura: a long-term prospective study in Greek children. J Clin Rheumatol. 2008;14:324-31. DOI: https://doi.org/10.1097/RHU.0b013e31817a240a.
25. Wang K, Sun X, Cao Y, Dai L, Sun F, Yu P, et al. Risk factors for kidney involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: a retrospective study. Medicine (Baltimore). 2018;97:38(e12520). DOI: https://doi.org/10.1097/MD.0000000000012520.
26. Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet. 1992;339:280-2. DOI: https://doi.org/10.1016/0140-6736(92)91341-5.
27. Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A. Predictive factors of kidney involvement or relapsing disease in children with Henoch-Schönlein purpura. Rheumatol Int. 2005;25:45-8. DOI: https://doi.org/10.1007/s00296-004-0452-2.
28. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345-50. DOI: https://doi.org/10.1038/ni0407-345.
29. Park SJ, Suh JS, Lee JH, Lee JW, Kim SH, Han KH, et al. Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis. Expert Rev Clin Immunol. 2013;9:1223-38. DOI: https://doi.org/10.1586/1744666X.2013.850028.
30. Nah EH, Kim S, Cho S, Cho HI. Complete blood count reference intervals and patterns of changes across pediatric, adult, and geriatric ages in Korea. Ann Lab Med. 2018;38:503-11. DOI: https://doi.org/10.3343/alm.2018.38.6.503.
31. Elmas AT, Tabel Y. Platelet counts in children with Henoch-Schonlein purpura-relationship to kidney involvement. J Clin Lab Anal. 2016;30:71-4. DOI: https://doi.org/10.1002/jcla.21817.
32. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001;98:2720-5. DOI: https://doi.org/10.1182/blood.V98.9.2720.
33. Yang M, Zhou M, Li SY, Chong B, Li XJ. IL-1? plays an important role on thrombocytosis in an immune vasculitis model via promoting megakaryopoiesis. Blood. 2013;122:2325. DOI: https://doi.org/10.1182/blood.v122.21.2325.2325.
34. Saulsbury FT, Kesler RW. Thrombocytosis in Henoch-Schönlein purpura. Clin Pediatr (Phila). 1983;22: 185–7. DOI: https://doi.org/10.1177/000992288302200305.
35. Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. J Microbiol Immunol Infect. 2006;39: 476-82.
36. Huber AM, King J, McLaine P, Klassen T, Pothos M. A randomized, placebo-controlled trial of prednisone in early Henoch-Schönlein purpura. BMC Med. 2004;2:7. DOI: https://doi.org/10.1186/1741-7015-2-7.
37. Chartapisak W, Opastirakul S, Hodson EM, Willis NS, Craig JC. Interventions for preventing and treating kidney disease in Henoch-Schönlein purpura (HSP). Cochrane Database Syst Rev. 2009;3:CD005128. DOI: https://doi.org/10.1002/14651858.CD005128.pub2.